BLI-1008

N/A

Report date: 2022/06/06 14:11:59
NME

Base Information

Drug NameBLI-1008
Drug Alias NameBLI-1008
ClassificationNatural product/Extract
Mechanisms of ActionNorepinephrine transporter inhibitors
TargetsNorepinephrine transporter
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedical And Pharmaceutical Industry Technology And Development Center
China Registration ClassN/A

Develop Information

Active CompaniesMedical And Pharmaceutical Industry Technology And Development CenterAmerican BrivisionBiolite Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A